Background: Peanut allergy is recognized as one of the most severe food allergies. Some studies have investigated the effects of enzymatic treatments on the in vitro immunological reactivity of members of the Leguminosae family, such as the soybean, chickpea and lentil. Nevertheless, there are only a few studies carried out with sera from patients with a well-documented allergy. Methods: Roasted peanut protein extract was hydrolyzed by the sequential and individual action of 2 food-grade enzymes, an endoprotease (Alcalase) and an exoprotease (Flavourzyme). Immunoreactivity to roasted peanut extract and hydrolyzed samples was evaluated by means of IgE immunoblot, ELISA and 2-dimensional electrophoresis using sera from 5 patients with a clinical allergy to peanuts and anti-Ara h 1, anti-Ara h 2 and anti-Ara h 3 immunoblots. Results: Immunoblot and ELISA assays showed an important decrease of IgE reactivity and Ara h 1, Ara h 2 and Ara h 3 levels in the first 30 min of hydrolyzation with Alcalase. In contrast, individual treatment with Flavourzyme caused an increase in IgE reactivity detected by ELISA at 30 min and led to a 65% inhibition of IgE reactivity at the end of the assay (300 min). Ara h 1 and the basic subunit of Ara h 3 were still recognized after treatment with Flavourzyme for 300 min. Conclusion: Hydrolysis with the endoprotease Alcalase decreases IgE reactivity in the soluble protein fraction of roasted peanut better than hydrolysis with the exoprotease Flavourzyme.

Keywords:
Enzymatic hydrolysis, Food allergy, Legumes, Roasted peanut
1.
Sicherer SH, Sampson HA: Peanut allergy: emerging concepts and approaches for an apparent epidemic. J Allergy Clin Immunol 2007;120:491–503.
2.
Sicherer SH, Muñoz-Furlong A, Godbold JH, Sampson HA: US prevalence of self-reported peanut, tree nut, and sesame allergy: 11-year follow-up. J Allergy Clin Immunol 2010;125:1322–1326.
3.
Merritt RJ, Carter M, Haight M, Eisenberg LD: Whey protein hydrolysate formula for infants with gastrointestinal intolerance to cow milk and soy protein in infant formulas. J Pediatr Gastroenterol Nutr 1990;11:78–82.
4.
Terracciano L, Isoardi P, Arrigoni S, Zoja A, Martelli A: Use of hydrolysates in the treatment of cow’s milk allergy. Ann Allergy Asthma Immunol 2002;89:86–90.
5.
Clemente A, Vioque J, Sanchez-Vioque R, Pedroche J, Millan F: Production of extensive chickpea (Cicer arietinum L.), protein hydrolysates with reduced antigenic activity. J Agric Food Chem1999;47:3776–3781.
6.
Cabanillas B, Pedrosa MM, Rodríguez J, González A, Muzquiz M, Cuadrado C, Crespo JF, Burbano C: Effects of enzymatic hydrolysis on lentil allergenicity. Mol Nutr Food Res 2010;54:1266–1277.
7.
Fritsché R: Utility of animal models for evaluating hypoallergenicity. Mol Nutr Food Res 2009;53:979–983.
8.
Clemente A: Enzymatic protein hydrolysates in human nutrition. Trends Food Sci Technol 2000;11:254–262.
9.
Walker Smith J: Hypoallergenic formulas: are they really hypoallergenic? Ann Allergy Asthma Immunol 2003;90:112–114.
10.
Docena G, Rozenfeld P, Fernandez R, Fossati CA: Evaluation of the residual antigenicity and allergenicity of cow’s milk substitutes by in vitro tests. Allergy 2002;57:83–91.
11.
Humiski LM, Aluko RE: Physicochemical and bitterness properties of enzymatic pea protein hydrolysates. J Food Sci 2007;72:S605–S611.
12.
Cuadrado C, Cabanillas B, Pedrosa MM, Varela A, Guillamón E, Muzquiz M, Crespo JF, Rodriguez J, Burbano C: Influence of thermal processing on IgE reactivity to lentil and chickpea proteins. Mol Nutr Food Res 2009;53:1462–1468.
13.
Adler-Nissen J: Determination of the degree of hydrolysis of food protein hydrolysates by trinitrobenzenesulfonic acid. J Agric Food Chem 1979;27:1256–1262.
14.
Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680–685.
15.
Sanchez-Madrid F, Morago G, Corbi AL, Carreira J: Monoclonal antibodies to three distinct epitopes on human IgE: their use for determination of allergen-specific IgE. J Immunol Methods 1984;73:367–378.
16.
Moreno R, Martínez-Gomariz M, Yuste L, Gil C, Rojo F: The Pseudomonas putida Crc global regulator controls the hierarchical assimilation of amino acids in a complete medium: evidence from proteomic and genomic analyses. Proteomics 2009;9:2910–2928.
17.
Maleki SJ, Chung SY, Champagne ET, Raufman JP: The effects of roasting on the allergenic properties of peanut proteins. J Allergy Clin Immunol 2000;106:763–768.
18.
Beyer K, Morrow E, Li XM, Bardina L, Bannon GA, Burks AW, Sampson HA: Effects of cooking methods on peanut allergenicity. J Allergy Clin Immunol 2001;107:1077–1081.
19.
Maleki SJ, Viquez O, Jacks T, Dodo H, Champagne ET, Chung SY, Landry SJ: The major peanut allergen, Ara h 2, functions as a trypsin inhibitor, and roasting enhances this function. J Allergy Clin Immunol 2003;112:190–195.
20.
Chung SY, Champagne ET: Allergenicity of Maillard reaction products from peanut proteins. J Agric Food Chem 1999;47:5227–5231.
21.
Chung SY, Champagne ET: Association of end-product adducts with increased IgE binding of roasted peanuts. J Agric Food Chem 2001;49:3911–3916.
22.
Kopper RA, Odum NJ, Sen M, Helm RM, Stanley JS, Burks AW: Peanut protein allergens: the effect of roasting on solubility and allergenicity. Int Arch Allergy Immunol 2005;136:16–22.
23.
Restani P, Ballabio C, Corsini E, Fiocchi A, Isoardi P, Magni C, Poiesi C, Terracciano L, Duranti M: Identification of the basic subunit of Ara h 3 as the major allergen in a group of children allergic to peanuts. Ann Allergy Asthma Immunol 2005;94:262–266.
24.
Rabjohn P, Helm EM, Stanley JS, West CM, Sampson HA, Burks AW, Bannon GA: Molecular cloning and epitope analysis of the peanut allergen Ara h 3. J Clin Invest 1999;103:535–542.
25.
Koppelman SJ, Wensing M, Ertmann M, Knulst AC, Knol EF: Relevance of Ara h 1, Ara h 2 and Ara h 3 in peanut-allergic patients, as determined by immunoglobulin E Western blotting, basophil-histamine release and intracutaneous testing: Ara h 2 is the most important peanut allergen. Clin Exp Allergy 2004;34:583–590.
26.
Koppelman SJ, Knol EF, Vlooswijk RA, Wensing M, Knulst AC, Hefle SL, Gruppen H, Piersma S: Peanut allergen Ara h 3: isolation from peanuts and biochemical characterization. Allergy 2003;58:1144–1151.
27.
Guo B, Liang X, Chung SY, Maleki SJ: Proteomic screening points to the potential importance of Ara h 3 basic subunit in allergenicity of peanut. Inflamm Allergy Drug Targets 2008;7:163–166.
28.
Lee HW, Keum EH, Lee SJ, Sung DE, Chung DH, Lee SI, Oh S: Allergenicity of proteolytic hydrolysates of the soybean 11S globulin. J Food Sci 2007;72:168–172.
29.
Lusas EW: Food uses of peanut protein. J Am Oil Chem Soc 1979;56:425–430.
30.
Singh B, Singh U: Peanut as a source of protein for human foods. Plant Foods Hum Nutr 1991;41:165–177.
31.
Maleki SJ: Food processing: effects on allergenicity. Curr Opin Allergy Clin Immunol 2004;4:241–245.
32.
Schmitt DA, Nesbit JB, Hurlburt BK, Cheng H, Maleki SJ: Processing can alter the properties of peanut extract preparations. J Agric Food Chem 2010;58:1138–1140.
© 2011 S. Karger AG, Basel
2011
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.